Media Mentions

Eggschain Secures First Patent for Tracking Genetic Material via Blockchain

Eggschain Team 0

Eggschain Secures First Patent for Tracking Genetic Material via Blockchain Patented Chain of Custody Solution will Improve Fertility and IVF Processes by Securing Healthcare Data for Sperm, Eggs, Embryos, DNA, Blood, and Genomes

Business Wire

AUSTIN, Texas — July 15, 2021

Eggschain, a healthcare technology company that combines genetics and

blockchain to track genetic material, today announced its pioneering, patented

solution for tracking and tracing the storage and transfer of blood, genome,

tissues, organs, DNA, RNA, sperm, eggs, embryos, and other biospecimens. This

new supply chain solution aims to provide a universal tracing and tracking

platform to deliver peace of mind for people and families undergoing IVF, and

the professionals who until now have relied on a high-touch, low-tech approach

that is arduous and inconsistent. Eggschain’s technology provides newfound

clarity and thorough insight for medical professionals into the supply chain,

from initial donation to testing, transfer and storage of the biospecimen.

Eggschain is the first patented blockchain-based biospecimen management and

monitoring system that makes the IVF process more stable, transparent, and

trackable for patients. This system maintains the confidentiality of patients’

personal information and allows clinics to securely and safely track the

locations of biological specimens through a digital chain of custody. This

allows for complete transparency and integrity during the process of IVF and

prevents life altering mistakes such as supply loss and wrongful billing of

patients. Eggschain’s provenance technology will be used by fertility clinics,

hospitals, cryogenic centers, and medical labs for screening genetic material.

“The technology such as developed by Eggschain has not existed before in the

field of reproductive medicine. Blockchain is an incredibly powerful

technology that allows for secure recording and tracking of data, and the

implications for medical data and specimens are tremendous,” said Hugh S.

Taylor, MD, Chair of Obstetrics, Gynecology and Reproductive Sciences at Yale

University. “With infertility increasing globally along with the ability to

store biological materials, Eggschain will enable patients to monitor and

follow their biologic specimens. Eggschain provides secure and safe tracking

of embryos, eggs and sperm, so that their location and integrity are always

confidently verified and easily assured.”

Eggschain is a female-founded and -owned company created by Wei Escala, a

software engineer whose passion for women’s health drove her to develop a

secure platform to provide transparency and peace of mind for people and

families undergoing the emotional and physical demands of IVF. As CEO of

Eggschain, Wei has built an all-star team of collaborators comprising

technologists, business leaders, physicians and scientists, with a focus on

continuing to develop game-changing innovation for patients, doctors, clinics

and labs through the Eggschain platform.

“Our eggs, sperm, organs and other biospecimens are uniquely personal and

therefore precious, yet until now the average person hasn’t had a consistent

and secure way to track location and movement. Even clinics and labs have

lacked a universal tracking mechanism, creating unnecessary paperwork and

leaving room for human error,” said Wei Escala, CEO and founder of Eggschain.

“Eggschain uses the first patented blockchain technology to bring professional

grade information and data to the individual in a convenient and secure

format, and also simplifies and improves the tracking process for labs,

ensuring they are secure and inspection-ready.”

Eggschain uses the Stacks blockchain, which allows people to build

decentralized applications for Bitcoin, to secure genetic data in an immutable

and transparent fashion. This powerful solution to genetic materials tracking

helps healthcare professionals maintain a thorough record of the journey each

biospecimen has taken and helps mitigate any possible mix ups.

Eggschain recently joined a cohort of 25 blockchain developers being supported

by The Stacks Foundation  through the Stacks Accelerator Program. The

intensive three-month program is backed by a leading coalition of Stacks

partners, including the Stacks Foundation, Hiro Systems, Freehold, and Daemon

Technologies, which have committed an initial $4M USD to support more than one

hundred early-stage crypto technology entrepreneurs with funding, mentorship,

and access to the incredible community of Stacks developers.

For further information about Eggschain, please visit https://eggschain.com/.

About Eggschain, INC.

Eggschain is a healthcare technology company and thought leader in the

fertility, health tech, family-building and cryogenic preservation industries.

Patent-granted and cloud-based, Eggschain is the first blockchain-integrated

inventory management and chain of custody technology for tracking bio

specimens, including sperm, eggs, embryos, genome, stem cell, tissues and

organs, and other genetic material. In partnership with several of the world’s

leading experts in reproductive biology, endocrinology and high complexity

labs, Eggschain delivers medical grade information and data to individuals

undergoing IVF in a secure, transparent and universally trackable format, and

also provides the means for clinics to monitor their inventory, either

personal, such as oocytes and sperm, or lab-related, including equipment

inventory and maintenance scheduling. At its core, Eggschain strives to enable

better decision-making, preserving the hope of life and helping to advance

humanity.

About Stacks

Secure smart contracts and apps for Bitcoin. The Stacks ecosystem is a

collection of independent entities, developers, and community members working

to build a user-owned internet on Bitcoin. The Stacks 2.0 blockchain extends

the design of Bitcoin to enable secure apps and predictable Clarity smart

contracts without modifying Bitcoin itself, opening innovation on the network

for the first time. The Stacks cryptocurrency (STX) is used as fuel for

networking activity and contract execution and can be locked by STX holders

via ‘Stacking’ to earn Bitcoin (BTC) rewards for supporting blockchain

consensus. Stacks cryptocurrency was distributed to the general public through

the first-ever SEC qualified token offering in US history.

View source version on businesswire.com:

https://www.businesswire.com/news/home/20210715005316/en/

Contact:

Alex Broudy / stacks@wachsman.com

Categories: Media Mentions

Leave a comment

Leave a comment